Radiolabelled probes for improved health

This research focuses on the development of radioactive probes and imaging techniques which optimise the assessment of a functional status of a disease, and to tailor radio-ligands that enable the best therapeutic plan for patients.

The use of radiolabelled probes to improve health currently has two components:

• Follow up of disease progression and therapy benefits
• Help to adjust therapeutic strategy for each patient (personalised medicine)

There are three main directions for research:

• To develop novel radiochemistry methodology and radiolabelling techniques to improve radiolabelling efficiencies, and to decrease radiolabelling time via macro and microfluidic and microwave technologies
• To develop novel radioligands (small molecules, peptides, proteins, cells or particles) for imaging (PET, SPECT) and targeted radioisotope therapy
• To optimise imaging and quantification techniques for new radio-isotopes and various organs of interest